Business Description
Tenaya Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US87990A1060
Description
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.47 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -7.4 | |||||
| 3-Year EPS without NRI Growth Rate | -6 | |||||
| 3-Year FCF Growth Rate | 5.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.69 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.16 | |||||
| 9-Day RSI | 77.15 | |||||
| 14-Day RSI | 71 | |||||
| 6-1 Month Momentum % | -57.93 | |||||
| 12-1 Month Momentum % | 0.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.27 | |||||
| Quick Ratio | 5.27 | |||||
| Cash Ratio | 4.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.9 | |||||
| Shareholder Yield % | -17.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -82.66 | |||||
| ROA % | -68.75 | |||||
| ROIC % | -177.4 | |||||
| ROC (Joel Greenblatt) % | -234.45 | |||||
| ROCE % | -80.92 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.32 | |||||
| Price-to-Tangible-Book | 2.32 | |||||
| EV-to-EBIT | -1.59 | |||||
| EV-to-Forward-EBIT | -1.46 | |||||
| EV-to-EBITDA | -1.71 | |||||
| EV-to-Forward-EBITDA | -1.46 | |||||
| EV-to-Forward-Revenue | 48.93 | |||||
| EV-to-FCF | -2.05 | |||||
| Price-to-Net-Current-Asset-Value | 4.57 | |||||
| Price-to-Net-Cash | 5.06 | |||||
| Earnings Yield (Greenblatt) % | -62.89 | |||||
| FCF Yield % | -36.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TNYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tenaya Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.44 | ||
| Beta | 2.31 | ||
| Volatility % | 105.59 | ||
| 14-Day RSI | 71 | ||
| 14-Day ATR ($) | 0.379179 | ||
| 20-Day SMA ($) | 2.369 | ||
| 12-1 Month Momentum % | 0.53 | ||
| 52-Week Range ($) | 1.61 - 7.01 | ||
| Shares Outstanding (Mil) | 79.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tenaya Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tenaya Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tenaya Therapeutics Inc Frequently Asked Questions
What is Tenaya Therapeutics Inc(TNYA)'s stock price today?
The current price of TNYA is $3.29. The 52 week high of TNYA is $7.01 and 52 week low is $1.61.
When is next earnings date of Tenaya Therapeutics Inc(TNYA)?
The next earnings date of Tenaya Therapeutics Inc(TNYA) is 2025-03-18 Est..
Does Tenaya Therapeutics Inc(TNYA) pay dividends? If so, how much?
Tenaya Therapeutics Inc(TNYA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers